Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]

Affiliations

• ¹ European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: [email protected].
• ² European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
• ³ Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
• ⁴ Breast Center, Genolier Cancer Center, Genolier, Switzerland.
• ⁵ Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
• ⁶ Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
• ⁷ Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
• ⁸ Department of Medical Oncology, Fortis Hospital, Kolkata, India.
• ⁹ Medical Oncology Department, Hospital of Prato, Prato, Italy.
• ¹⁰ Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
• ¹¹ Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA.
• ¹² METAvivor Research and Support, Annapolis, USA.
• ¹³ Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.
• ¹⁴ Department of Medical Oncology, Institut Curie, Paris, France.
• ¹⁵ NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon.
• ¹⁶ Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania.
• ¹⁷ Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
• ¹⁸ Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
• ¹⁹ Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ²⁰ BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada.
• ²¹ Department of Medical Oncology, Galliera Hospital, Genoa, Italy.
• ²² Brustzentrum der Universitat München, Munich, Germany.
• ²³ Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA.
• ²⁴ Sheba Medical Center, Tel Hashomer, Israel.
• ²⁵ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
• ²⁶ Advanced BC.org, New York, USA.
• ²⁷ Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands.
• ²⁸ Metastatic Breast Cancer Network US, Inversness, USA.
• ²⁹ Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan.
• ³⁰ Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
• ³¹ Europa Donna, Nicosia, Cyprus.
• ³² Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
• ³³ Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
• ³⁴ Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France.
• ³⁵ Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
• ³⁶ Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA.
• ³⁷ Indiana University Medical CTR, Indianapolis, USA.
• ³⁸ Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
• ³⁹ Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany.
• ⁴⁰ Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK.
• ⁴¹ Sandton Oncology Centre, Johannesburg, South Africa.
• ⁴² Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
• ⁴³ Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.